Scientists showed that thyroid hormone receptor β (TRβ) was a newly identified transcription regulator that acted to suppress CSC activity and that TRβ could be considered as a molecular target for therapeutic intervention of anaplastic thyroid cancer cells.
[Oncogene]
Sorry, but the selected Zotpress account can't be found.
